Healthcare - Biotechnology - NASDAQ - IL
$ 1.73
-1.14 %
$ 63.7 M
Market Cap
-6.65
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--91.92%
Net Income
Estimate
66.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Entera Bio Ltd.
ENTX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ENTX
EBIT FORECAST
EBIT Forecast Chart ENTX
NET INCOME FORECAST
Net Income Chart ENTX